Wnt antagonists and their use in the diagnosis and treatment of Wntmediated disorders

Details for Australian Patent Application No. 2007292242 (hide)

Owner GENENTECH, INC.

Inventors Polakis, Paul; Rubinfeld, Bonnee; Ernst, James A.; Dealmeida, Venita I.

Agent Griffith Hack

Pub. Number AU-A-2007292242

PCT Pub. Number WO2008/031009

Priority 60/951,175 20.07.07 US; 60/825,063 08.09.06 US

Filing date 7 September 2007

Wipo publication date 13 March 2008

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/031009 Priority application(s): WO2008/031009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007292243-Systems and methods for historical display of surgical operating parameters

2007292239-Stabilized accommodating intraocular lens